60
Participants
Start Date
May 31, 2009
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
irbesartan
Irbesartan-tablet (150 mg) 1 in the morning for 7 days, 2 tablets (1 in the morning and 1 in the evening) after day 8 if no contraindication for up titration (investigator will decide on the basis of creatinin, urea and potassium after taking a blood sample) for 9 weeks.
placebo
Placebo-tablet, 1 in the morning for 7 days, 2 tablets (1 in the morning and 1 in the evening) after day 8.
RECRUITING
University Hospital Magdeburg; Div. of Cardiology, Magdeburg
Collaborators (1)
Sanofi
INDUSTRY
University of Magdeburg
OTHER